0001855763-23-000009.txt : 20231101 0001855763-23-000009.hdr.sgml : 20231101 20231101134534 ACCESSION NUMBER: 0001855763-23-000009 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231026 FILED AS OF DATE: 20231101 DATE AS OF CHANGE: 20231101 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Carle Vanessa CENTRAL INDEX KEY: 0001855763 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39874 FILM NUMBER: 231367552 MAIL ADDRESS: STREET 1: 100 - 740 MCCURDY ROAD CITY: KELOWNA STATE: A1 ZIP: V1X 2P7 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Lexaria Bioscience Corp. CENTRAL INDEX KEY: 0001348362 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 202000871 STATE OF INCORPORATION: NV FISCAL YEAR END: 0831 BUSINESS ADDRESS: STREET 1: 100 - 740 MCCURDY ROAD CITY: KELOWNA STATE: A1 ZIP: V1X 2P7 BUSINESS PHONE: 250-765-6424 MAIL ADDRESS: STREET 1: 100 - 740 MCCURDY ROAD CITY: KELOWNA STATE: A1 ZIP: V1X 2P7 FORMER COMPANY: FORMER CONFORMED NAME: LEXARIA CORP. DATE OF NAME CHANGE: 20080229 FORMER COMPANY: FORMER CONFORMED NAME: Lexaria Corp. DATE OF NAME CHANGE: 20051229 4 1 primary_doc.xml PRIMARY DOCUMENT X0508 4 2023-10-26 0 0001348362 Lexaria Bioscience Corp. LEXX 0001855763 Carle Vanessa 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 BRITISH COLUMBIA, CANADA 0 1 0 0 Secretary 0 common shares 67 D Warrants 36 2019-11-13 2024-11-13 Common Shares 67 67 D Stock Options 3 2021-04-26 2026-04-26 Common Shares 12500 12567 D Stock Options 3 2021-06-08 2026-06-08 Common Shares 5000 17567 D Stock Options 3 2021-09-01 2026-09-01 Common Shares 10000 27567 D Stock Options 2.91 2022-08-29 2027-08-29 Common Shares 12500 40067 D Stock Options 1.15 2023-10-26 4 A 0 12500 0 A 2023-10-26 2028-10-26 Common Shares 12500 52567 D Repriced from $5.31 pursuant to shareholder approval received on May 9, 2023 Repriced from $7.08 pursuant to shareholder approval received on May 9, 2023 Repriced from $6.23 pursuant to shareholder approval received on May 9, 2023 /Vanessa Carle/ 2023-11-01